Polynovo Ltd | PNV

Polynovo Ltd traded at 1.53 this Thursday July 7th, increasing 0.05 or 3.03 percent since the previous trading session. Looking back, over the last four weeks, Polynovo Ltd gained 31.90 percent. Over the last 12 months, its price fell by 35.71 percent. Looking ahead, we forecast Polynovo Ltd to be priced at 1.27 by the end of this quarter and at 1.19 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1.53
Daily Change
3.03%
Yearly
-35.71%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Avita Therapeutics Inc 1.70 0.04 2.11% -67.84%
Ansell 23.44 0.57 2.49% -43.41%
Cochlear 202.41 -0.57 -0.28% -17.87%
CSL 285.49 -0.65 -0.23% 2.27%
Healius Ltd 3.73 0.03 0.81% -19.96%
Integral Diagnostics Ltd 3.00 0.03 1.01% -41.86%
Mayne Pharma 0.29 0.02 5.56% -14.93%
Nanosonics Ltd 3.94 -0.02 -0.51% -24.95%
Next Science Ltd 0.82 -0.03 -3.55% -47.59%
Ramsay Health Care 69.90 -0.94 -1.33% 8.57%
ResMed 32.04 -0.46 -1.42% -4.39%
Sonic Healthcare 33.59 0.21 0.61% -10.84%
Telix Pharmaceuticals Ltd 5.19 0.39 8.13% -9.11%

Indexes Price Day Year
AUALL 6805 20.30 0.30% -10.64%
AU200 6617 22.40 0.34% -9.87%

Polynovo Ltd
PolyNovo Limited is an Australia-based medical devices company. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. It can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.